arXiv subjects

Alexandra Ertl

Publications and source records attributed to Alexandra Ertl.

4 recordsLinked to original sources

arXiv2026

TwinTrack: Post-hoc Multi-Rater Calibration for Medical Image Segmentation

Pancreatic ductal adenocarcinoma (PDAC) segmentation on contrast-enhanced CT is inherently ambiguous: inter-rater disagreement among experts reflects genuine uncertainty rather than annotation noise. Standard deep learning approaches assume a single ground truth, producing probabilistic outputs that can be poorly calibrated and difficult to interpret under such ambiguity. We present TwinTrack, a framework that addresses this gap through post-hoc calibration of ensemble segmentation probabilities to the empirical mean human response (MHR) -the fraction of expert annotators labeling a voxel as tumor. Calibrated probabilities are thus directly interpretable as the expected proportion of annotators assigning the tumor label, explicitly modeling inter-rater disagreement. The proposed post-hoc calibration procedure is simple and requires only a small multi-rater calibration set. It consistently improves calibration metrics over standard approaches when evaluated on the MICCAI 2025 CURVAS-PDACVI multi-rater benchmark.

cs.LG↗

arXiv2026

The MAMA-MIA Challenge: Advancing Generalizability and Fairness in Breast MRI Tumor Segmentation and Treatment Response Prediction

Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Dynamic contrast-enhanced magnetic resonance imaging plays a central role in tumor characterization and treatment monitoring, particularly in patients receiving neoadjuvant chemotherapy. However, existing artificial intelligence models for breast magnetic resonance imaging are typically developed and evaluated using heterogeneous datasets, study populations, and assessment protocols, making direct comparison difficult and limiting understanding of model robustness across institutions and clinically relevant patient subgroups. The MAMA-MIA Challenge was designed to address these challenges by providing a standardized benchmark for the joint evaluation of primary tumor segmentation and prediction of pathologic complete response using pre-treatment magnetic resonance imaging only. The training cohort comprised 1,506 patients from multiple institutions in the United States, while evaluation was conducted on an external test set of 574 patients from three independent European centers to assess cross-continental and cross-institutional generalization. A unified scoring framework combined predictive performance with subgroup consistency across age, menopausal status, and breast density. Twenty-six international teams participated in the final evaluation phase. Results demonstrate substantial performance variability under a common external evaluation framework and reveal trade-offs between overall accuracy and subgroup fairness. The challenge provides standardized datasets, evaluation protocols, and public resources to promote the development of robust and equitable artificial intelligence systems for breast cancer imaging.

cs.CV↗

arXiv2025

Deep Learning for Retinal Degeneration Assessment: A Comprehensive Analysis of the MARIO Challenge

The MARIO challenge, held at MICCAI 2024, focused on advancing the automated detection and monitoring of age-related macular degeneration (AMD) through the analysis of optical coherence tomography (OCT) images. Designed to evaluate algorithmic performance in detecting neovascular activity changes within AMD, the challenge incorporated unique multi-modal datasets. The primary dataset, sourced from Brest, France, was used by participating teams to train and test their models. The final ranking was determined based on performance on this dataset. An auxiliary dataset from Algeria was used post-challenge to evaluate population and device shifts from submitted solutions. Two tasks were involved in the MARIO challenge. The first one was the classification of evolution between two consecutive 2D OCT B-scans. The second one was the prediction of future AMD evolution over three months for patients undergoing anti-vascular endothelial growth factor (VEGF) therapy. Thirty-five teams participated, with the top 12 finalists presenting their methods. This paper outlines the challenge's structure, tasks, data characteristics, and winning methodologies, setting a benchmark for AMD monitoring using OCT, infrared imaging, and clinical data (such as the number of visits, age, gender, etc.). The results of this challenge indicate that artificial intelligence (AI) performs as well as a physician in measuring AMD progression (Task 1) but is not yet able of predicting future evolution (Task 2).

cs.CV↗

arXiv2025

nnLandmark: A Self-Configuring Method for 3D Medical Landmark Detection

Landmark detection is central to many medical applications, such as identifying critical structures for treatment planning or defining control points for biometric measurements. However, manual annotation is labor-intensive and requires expert anatomical knowledge. While deep learning shows promise in automating this task, fair evaluation and interpretation of methods in a broader context are hindered by limited public benchmarking, inconsistent baseline implementations, and non-standardized experimentation. To overcome these pitfalls, we present nnLandmark, a self-configuring framework for 3D landmark detection that combines tailored heatmap generation, loss design, inference logic, and a robust set of hyperparameters for heatmap regression, while reusing components from nnU-Net's underlying self-configuration and training engine. nnLandmark achieves state-of-the-art performance across five public and one private dataset, benchmarked against three recently published methods. Its out-of-the-box usability enables training strong landmark detection models on new datasets without expert knowledge or dataset-specific hyperparameter tuning. Beyond accuracy, nnLandmark provides both a strong, common baseline and a flexible, standardized environment for developing and evaluating new methodological contributions. It further streamlines evaluation across multiple datasets by offering data conversion utilities for current public benchmarks. Together, these properties position nnLandmark as a central tool for advancing 3D medical landmark detection through systematic, transparent benchmarking, enabling to genuinely measure methodological progress. The code is available on GitHub: https://github.com/MIC-DKFZ/nnLandmark

cs.CV↗